MRK logo

Merck & Co., Inc. (MRK) EBITDA

Annual EBITDA:

$25.14B+$18.29B(+266.84%)
December 31, 2024

Summary

  • As of today, MRK annual EBITDA is $25.14 billion, with the most recent change of +$18.29 billion (+266.84%) on December 31, 2024.
  • During the last 3 years, MRK annual EBITDA has risen by +$6.31 billion (+33.51%).
  • MRK annual EBITDA is now at all-time high.

Performance

MRK EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

Quarterly EBITDA:

$8.54B+$1.12B(+15.10%)
September 1, 2025

Summary

  • As of today, MRK quarterly EBITDA is $8.54 billion, with the most recent change of +$1.12 billion (+15.10%) on September 1, 2025.
  • Over the past year, MRK quarterly EBITDA has increased by +$3.08 billion (+56.58%).
  • MRK quarterly EBITDA is now at all-time high.

Performance

MRK Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

TTM EBITDA:

$29.85B+$3.08B(+11.52%)
September 1, 2025

Summary

  • As of today, MRK TTM EBITDA is $29.85 billion, with the most recent change of +$3.08 billion (+11.52%) on September 1, 2025.
  • Over the past year, MRK TTM EBITDA has increased by +$11.19 billion (+59.92%).
  • MRK TTM EBITDA is now at all-time high.

Performance

MRK TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MRK EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+266.8%+56.6%+59.9%
3Y3 Years+33.5%+35.7%+20.0%
5Y5 Years+46.8%+102.7%+80.7%

MRK EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+266.8%at high+313.6%at high+331.7%
5Y5-Yearat high+266.8%at high+313.6%at high+331.7%
All-TimeAll-Timeat high+3513.1%at high+313.6%at high+3685.7%

MRK EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$8.54B(+15.1%)
$29.85B(+11.5%)
Jun 2025
-
$7.42B(-5.0%)
$26.77B(+0.3%)
Mar 2025
-
$7.81B(+28.2%)
$26.68B(+3.5%)
Dec 2024
$25.14B(+266.8%)
$6.09B(+11.7%)
$25.78B(+38.1%)
Sep 2024
-
$5.45B(-25.7%)
$18.66B(-7.7%)
Jun 2024
-
$7.33B(+6.3%)
$20.22B(+127.4%)
Mar 2024
-
$6.90B(+776.6%)
$8.89B(+28.6%)
Dec 2023
$6.85B(-70.7%)
-$1.02B(-114.6%)
$6.92B(-41.6%)
Sep 2023
-
$7.00B(+275.3%)
$11.84B(+6.4%)
Jun 2023
-
-$4.00B(-181.1%)
$11.13B(-48.1%)
Mar 2023
-
$4.93B(+26.1%)
$21.45B(-8.4%)
Dec 2022
$23.41B(+24.3%)
$3.91B(-37.9%)
$23.41B(-5.9%)
Sep 2022
-
$6.29B(-0.6%)
$24.88B(+2.4%)
Jun 2022
-
$6.33B(-8.1%)
$24.29B(+10.2%)
Mar 2022
-
$6.88B(+28.1%)
$22.04B(+17.2%)
Dec 2021
$18.83B(+39.0%)
$5.38B(-5.8%)
$18.80B(+23.8%)
Sep 2021
-
$5.70B(+40.0%)
$15.19B(+10.9%)
Jun 2021
-
$4.08B(+11.6%)
$13.69B(+4.3%)
Mar 2021
-
$3.65B(+107.7%)
$13.13B(-8.6%)
Dec 2020
$13.55B(-20.9%)
$1.76B(-58.3%)
$14.36B(-13.1%)
Sep 2020
-
$4.21B(+19.8%)
$16.52B(-1.3%)
Jun 2020
-
$3.51B(-28.0%)
$16.73B(-5.3%)
Mar 2020
-
$4.88B(+24.5%)
$17.67B(+3.1%)
Dec 2019
$17.13B(+20.6%)
$3.92B(-11.4%)
$17.13B(-1.0%)
Sep 2019
-
$4.42B(-0.7%)
$17.32B(+4.2%)
Jun 2019
-
$4.45B(+2.5%)
$16.62B(+6.9%)
Mar 2019
-
$4.34B(+5.9%)
$15.55B(+14.3%)
Dec 2018
$14.20B(+18.1%)
$4.10B(+9.9%)
$13.60B(+2.4%)
Sep 2018
-
$3.73B(+10.4%)
$13.28B(+19.5%)
Jun 2018
-
$3.38B(+40.9%)
$11.11B(-2.7%)
Mar 2018
-
$2.40B(-36.5%)
$11.42B(-8.9%)
Dec 2017
$12.02B(-24.5%)
$3.78B(+142.2%)
$12.53B(-5.0%)
Sep 2017
-
$1.56B(-57.7%)
$13.19B(-17.0%)
Jun 2017
-
$3.69B(+5.0%)
$15.90B(+0.1%)
Mar 2017
-
$3.51B(-20.8%)
$15.89B(-0.4%)
Dec 2016
$15.93B(+15.3%)
$4.43B(+3.9%)
$15.95B(+9.5%)
Sep 2016
-
$4.27B(+16.1%)
$14.57B(+2.8%)
Jun 2016
-
$3.68B(+2.8%)
$14.18B(+1.3%)
Mar 2016
-
$3.58B(+17.1%)
$14.00B(+1.0%)
Dec 2015
$13.81B(-13.0%)
$3.05B(-21.1%)
$13.86B(-1.4%)
Sep 2015
-
$3.87B(+10.6%)
$14.05B(-8.5%)
Jun 2015
-
$3.50B(+2.1%)
$15.35B(-3.8%)
Mar 2015
-
$3.43B(+5.5%)
$15.95B(-3.7%)
Dec 2014
$15.88B(-2.6%)
$3.25B(-37.1%)
$16.57B(-6.8%)
Sep 2014
-
$5.17B(+26.0%)
$17.78B(+5.0%)
Jun 2014
-
$4.10B(+1.3%)
$16.93B(+1.5%)
Mar 2014
-
$4.05B(-9.2%)
$16.68B(+2.5%)
Dec 2013
$16.30B(-9.1%)
$4.46B(+3.4%)
$16.28B(+3.8%)
Sep 2013
-
$4.32B(+12.0%)
$15.68B(+0.0%)
Jun 2013
-
$3.85B(+5.8%)
$15.68B(-6.8%)
Mar 2013
-
$3.64B(-5.8%)
$16.82B(-6.2%)
Dec 2012
$17.93B(-1.6%)
$3.87B(-10.4%)
$17.93B(-3.0%)
Sep 2012
-
$4.32B(-13.6%)
$18.48B(-1.4%)
Jun 2012
-
$5.00B(+5.1%)
$18.74B(+1.9%)
Mar 2012
-
$4.75B(+7.8%)
$18.40B(+1.0%)
Dec 2011
$18.22B(+28.7%)
$4.41B(-3.7%)
$18.22B(+3.0%)
Sep 2011
-
$4.58B(-1.6%)
$17.69B(+4.4%)
Jun 2011
-
$4.66B(+1.9%)
$16.95B(+5.2%)
Mar 2011
-
$4.57B(+17.6%)
$16.11B(+12.1%)
Dec 2010
$14.15B(+92.1%)
$3.89B(+1.2%)
$14.38B(+21.9%)
Sep 2010
-
$3.84B(+0.7%)
$11.79B(+16.7%)
Jun 2010
-
$3.81B(+34.5%)
$10.11B(+21.0%)
Mar 2010
-
$2.84B(+117.9%)
$8.35B(+15.0%)
Dec 2009
$7.37B(-8.0%)
$1.30B(-39.6%)
$7.26B(-7.8%)
Sep 2009
-
$2.16B(+4.8%)
$7.88B(+1.4%)
Jun 2009
-
$2.06B(+17.6%)
$7.77B(+1.4%)
Mar 2009
-
$1.75B(-8.9%)
$7.66B(-4.4%)
Dec 2008
$8.01B(+0.6%)
$1.92B(-6.2%)
$8.01B(+2.0%)
Sep 2008
-
$2.05B(+5.1%)
$7.85B(+1.3%)
Jun 2008
-
$1.95B(-7.2%)
$7.74B(-3.1%)
Mar 2008
-
$2.10B(+19.3%)
$8.00B(-0.7%)
Dec 2007
$7.96B(+5.3%)
$1.76B(-9.5%)
$8.05B(+3.6%)
Sep 2007
-
$1.94B(-11.7%)
$7.77B(+8.8%)
Jun 2007
-
$2.20B(+2.1%)
$7.15B(-3.0%)
Mar 2007
-
$2.15B(+45.4%)
$7.37B(-1.9%)
Dec 2006
$7.56B(-2.6%)
$1.48B(+12.8%)
$7.51B(-4.5%)
Sep 2006
-
$1.31B(-45.8%)
$7.86B(-7.1%)
Jun 2006
-
$2.42B(+5.6%)
$8.46B(+5.2%)
Mar 2006
-
$2.29B(+25.3%)
$8.05B(+3.6%)
Dec 2005
$7.76B(-14.2%)
$1.83B(-4.5%)
$7.76B(-2.2%)
Sep 2005
-
$1.92B(-4.4%)
$7.94B(+0.4%)
Jun 2005
-
$2.00B(-0.3%)
$7.91B(-3.5%)
Mar 2005
-
$2.01B(+0.1%)
$8.20B(-4.3%)
Dec 2004
$9.05B
$2.01B(+6.5%)
$8.56B(-2.1%)
Sep 2004
-
$1.89B(-17.5%)
$8.74B(-7.8%)
DateAnnualQuarterlyTTM
Jun 2004
-
$2.29B(-3.8%)
$9.48B(-3.8%)
Mar 2004
-
$2.38B(+8.6%)
$9.85B(-4.6%)
Dec 2003
$9.97B(-9.0%)
$2.19B(-16.5%)
$10.33B(-6.2%)
Sep 2003
-
$2.62B(-1.6%)
$11.02B(-2.9%)
Jun 2003
-
$2.66B(-6.6%)
$11.35B(-0.5%)
Mar 2003
-
$2.85B(-0.8%)
$11.40B(+2.7%)
Dec 2002
$10.95B(-2.2%)
$2.88B(-2.5%)
$11.11B(+1.7%)
Sep 2002
-
$2.95B(+8.4%)
$10.91B(-2.7%)
Jun 2002
-
$2.72B(+6.5%)
$11.21B(-1.5%)
Mar 2002
-
$2.56B(-4.8%)
$11.38B(+0.3%)
Dec 2001
$11.19B(+8.0%)
$2.69B(-17.4%)
$11.35B(-0.8%)
Sep 2001
-
$3.25B(+12.4%)
$11.44B(+4.0%)
Jun 2001
-
$2.89B(+14.6%)
$11.01B(+1.8%)
Mar 2001
-
$2.52B(-9.1%)
$10.81B(+1.2%)
Dec 2000
$10.37B(+18.6%)
$2.78B(-1.4%)
$10.69B(+7.1%)
Sep 2000
-
$2.82B(+4.4%)
$9.98B(+5.2%)
Jun 2000
-
$2.70B(+12.5%)
$9.49B(+4.7%)
Mar 2000
-
$2.40B(+15.9%)
$9.06B(+3.7%)
Dec 1999
$8.74B(+18.2%)
$2.07B(-11.1%)
$8.74B(-13.8%)
Sep 1999
-
$2.33B(+2.3%)
$10.14B(+17.7%)
Jun 1999
-
$2.27B(+9.7%)
$8.61B(+8.0%)
Mar 1999
-
$2.07B(-40.2%)
$7.97B(+8.6%)
Dec 1998
$7.39B(+13.6%)
$3.47B(+332.6%)
$7.34B(+17.7%)
Sep 1998
-
$801.40M(-51.0%)
$6.24B(-9.6%)
Jun 1998
-
$1.64B(+13.6%)
$6.90B(+1.6%)
Mar 1998
-
$1.44B(-39.0%)
$6.79B(+1.3%)
Dec 1997
$6.50B(+13.8%)
$2.36B(+61.3%)
$6.70B(+4.0%)
Sep 1997
-
$1.46B(-4.0%)
$6.44B(+1.9%)
Jun 1997
-
$1.52B(+12.7%)
$6.32B(+3.2%)
Mar 1997
-
$1.35B(-35.6%)
$6.13B(+3.7%)
Dec 1996
$5.72B(+12.7%)
$2.10B(+56.0%)
$5.91B(+5.2%)
Sep 1996
-
$1.35B(+1.1%)
$5.62B(+2.4%)
Jun 1996
-
$1.33B(+17.4%)
$5.48B(+2.3%)
Mar 1996
-
$1.13B(-37.2%)
$5.36B(+1.9%)
Dec 1995
$5.07B(-0.2%)
$1.81B(+48.9%)
$5.26B(+0.4%)
Sep 1995
-
$1.21B(+0.2%)
$5.24B(+0.0%)
Jun 1995
-
$1.21B(+17.2%)
$5.24B(-0.7%)
Mar 1995
-
$1.03B(-42.2%)
$5.28B(-0.1%)
Dec 1994
$5.08B(+18.9%)
$1.79B(+47.6%)
$5.28B(+0.2%)
Sep 1994
-
$1.21B(-2.8%)
$5.27B(+4.0%)
Jun 1994
-
$1.25B(+20.2%)
$5.07B(+25.6%)
Mar 1994
-
$1.04B(-41.7%)
$4.03B(+3.8%)
Dec 1993
$4.27B(-11.2%)
$1.78B(+76.5%)
$3.89B(+32.0%)
Sep 1993
-
$1.01B(+373.8%)
$2.94B(+4.0%)
Jun 1993
-
$212.40M(-76.1%)
$2.83B(-20.3%)
Mar 1993
-
$890.30M(+6.7%)
$3.55B(+1.7%)
Dec 1992
$4.81B(+42.7%)
$834.40M(-6.5%)
$3.49B(+1.4%)
Sep 1992
-
$892.80M(-4.2%)
$3.44B(+3.1%)
Jun 1992
-
$931.70M(+11.9%)
$3.34B(+1.6%)
Mar 1992
-
$832.60M(+6.1%)
$3.29B(+1.4%)
Dec 1991
$3.37B(+16.1%)
$784.50M(-0.7%)
$3.24B(+3.4%)
Sep 1991
-
$790.40M(-10.2%)
$3.14B(+3.9%)
Jun 1991
-
$880.30M(+11.9%)
$3.02B(+6.5%)
Mar 1991
-
$786.50M(+16.0%)
$2.84B(+6.9%)
Dec 1990
$2.91B(+18.2%)
$678.10M(+0.6%)
$2.65B(+5.0%)
Sep 1990
-
$673.80M(-3.3%)
$2.53B(+3.9%)
Jun 1990
-
$696.80M(+15.6%)
$2.43B(-26.8%)
Mar 1990
-
$602.70M(+9.1%)
$3.32B(-22.6%)
Dec 1989
$2.46B(+18.6%)
$552.40M(-4.7%)
$4.29B(+258.1%)
Sep 1989
-
$579.60M(-63.4%)
$1.20B(-42.6%)
Jun 1989
-
$1.59B(+0.9%)
$2.09B(+4.3%)
Mar 1989
-
$1.57B(+161.9%)
$2.00B(+7.2%)
Dec 1988
$2.07B(+31.2%)
-$2.54B(-272.8%)
$1.87B(-11.4%)
Sep 1988
-
$1.47B(-2.1%)
$2.11B(+8.3%)
Jun 1988
-
$1.50B(+4.4%)
$1.95B(+14.8%)
Mar 1988
-
$1.44B(+162.5%)
$1.69B(+23.8%)
Dec 1987
$1.58B(+27.9%)
-$2.30B(-275.9%)
$1.37B(-20.8%)
Sep 1987
-
$1.31B(+4.6%)
$1.73B(+17.1%)
Jun 1987
-
$1.25B(+12.4%)
$1.48B(+19.8%)
Mar 1987
-
$1.11B(+157.3%)
$1.23B(+18.2%)
Dec 1986
$1.24B(+20.8%)
-$1.94B(-284.0%)
$1.04B(-15.4%)
Sep 1986
-
$1.05B(+4.8%)
$1.23B(+19.2%)
Jun 1986
-
$1.00B(+9.1%)
$1.03B(+14.1%)
Mar 1986
-
$921.10M(+152.6%)
$904.60M(+7.7%)
Dec 1985
$1.02B(+6.6%)
-$1.75B(-304.5%)
$839.80M(+6.5%)
Sep 1985
-
$855.80M(-2.5%)
$788.50M(-0.3%)
Jun 1985
-
$877.40M(+2.5%)
$790.60M(-1.7%)
Mar 1985
-
$856.30M(+147.5%)
$804.50M(+1.0%)
Dec 1984
$958.68M(+10.1%)
-$1.80B(-309.9%)
$796.80M(-69.3%)
Sep 1984
-
$857.90M(-3.7%)
$2.60B(+49.3%)
Jun 1984
-
$891.30M(+5.0%)
$1.74B(+105.0%)
Mar 1984
-
$848.60M
$848.60M
Dec 1983
$871.11M(+14.2%)
-
-
Dec 1982
$762.59M(+9.6%)
-
-
Dec 1981
$695.88M(-7.3%)
-
-
Dec 1980
$750.37M
-
-

FAQ

  • What is Merck & Co., Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Merck & Co., Inc.?
  • What is Merck & Co., Inc. annual EBITDA year-on-year change?
  • What is Merck & Co., Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Merck & Co., Inc.?
  • What is Merck & Co., Inc. quarterly EBITDA year-on-year change?
  • What is Merck & Co., Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Merck & Co., Inc.?
  • What is Merck & Co., Inc. TTM EBITDA year-on-year change?

What is Merck & Co., Inc. annual EBITDA?

The current annual EBITDA of MRK is $25.14B

What is the all-time high annual EBITDA for Merck & Co., Inc.?

Merck & Co., Inc. all-time high annual EBITDA is $25.14B

What is Merck & Co., Inc. annual EBITDA year-on-year change?

Over the past year, MRK annual EBITDA has changed by +$18.29B (+266.84%)

What is Merck & Co., Inc. quarterly EBITDA?

The current quarterly EBITDA of MRK is $8.54B

What is the all-time high quarterly EBITDA for Merck & Co., Inc.?

Merck & Co., Inc. all-time high quarterly EBITDA is $8.54B

What is Merck & Co., Inc. quarterly EBITDA year-on-year change?

Over the past year, MRK quarterly EBITDA has changed by +$3.08B (+56.58%)

What is Merck & Co., Inc. TTM EBITDA?

The current TTM EBITDA of MRK is $29.85B

What is the all-time high TTM EBITDA for Merck & Co., Inc.?

Merck & Co., Inc. all-time high TTM EBITDA is $29.85B

What is Merck & Co., Inc. TTM EBITDA year-on-year change?

Over the past year, MRK TTM EBITDA has changed by +$11.19B (+59.92%)
On this page